Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.

The Johns Hopkins spinout will funnel the cash into developing a class of glutamine antagonist that could help treat cancer.

Mythic, an AI chip developer that emerged out of UM, has closed a $40m round led by SoftBank Ventures that included another corporate venturing unit, Lockheed Martin Ventures.

GV and Walden International co-led the Stanford spinout's series A round, which was announced as it emerged out of stealth.

Purdue spinout On Target Laboratories has closed a series B round at $44m after an $11.1m extension featuring Helsinn.

Commonwealth Fusion Systems, based on MIT research, has launched with $50m in initial capital from energy company Eni to develop fusion power.

UC-RNT has put up $16m for the Flipkart-backed rental services provider's latest round, taking its funding past the $90m mark.

The neurodegenerative disease treatment spinout from University of Aberdeen has disclosed it raised $71m through a rights issue in October.